• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]


Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





NO
     
ICCC [ ImmuCell Corp ]
Last Trade 9.3973 Date 5/19/2021
Change % -4.99 % Price Change -0.50
Open 9.915 52 Week High 13.2
High 9.915 52 Week Low 3.81
Low 9.3201 Type stock
Volume 14971 Average Volume 78365
Prev Close 9.89 Stock Exchange NASDAQ
Bid 8.03 Ask 10.12
Bid Size 19 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share Book Value Yield
Buy Back Yield CAPE Ratio
Cash Return Cash Flow per Share
Cash Flow Yield Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue EV / Total Asset
Expected Dividend Growth Rate Free Cash Flow per Share
Free Caash Flow Ratio Free Cash Flow Yield
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio
PB Ratio PB Ratio 10 Year Growth
PB Ratio 3 Year Growth Cash Ratio 3 Year Average
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average PE Ratio 10 Year Growth
PE Ratio 10 Year High PE Ratio 10 Year Low
PE Ratio 1 Year Avg PE Ratio 1 Year High
PE Ratio 1 Year Low PE Ratio 3 Year Avg
PE Ratio 5 Year Avg PE Ratio 5 Year High
PE Ratio 5 Year Low Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month
Price to Cash Ratio Price / EBITDA
Price to Sales Ratio Price to Sales Ratio 10 Year Growth
Price to Sales Ratio 3 Year Avg Price to Sales Ratio 5 Year Avg
Sale per Share Sales Yield
Sustainable Growth Rate Tangible Book Value per Share
Tangible Book Value per Share 3 year Avg Tangible Book Value per Share 5 year Avg
Total Asset per Share Total Yield
Working Capital per Share Working Capital per Share 3 Year Avg
Working Capital per Share 5 Year Avg Beta
Company Profile

ImmuCell Corporation, a biotechnology company, engages in developing, manufacturing, and selling products that improve animal health and productivity in the dairy and beef industries in the United States and internationally. Its lead product, First Defense, is an orally delivered scours preventative product for the treatment of bovine enteritis in newborn calves. The company also offers products that aid in the management of mastitis, an inflammation of the mammary gland caused by bacterial infections. These products comprise Wipe Out Dairy Wipes, which consist of pre-moistened and biodegradable towelettes that are impregnated with Nisin to prepare the teat area of a cow in advance of milking; MASTiK, an antibiotic susceptibility test, which helps veterinarians and producers in selecting antibiotics in the treatment of individual cases of mastitis; and California Mastitis Test (CMT), which is performed at cow-side for the early detection of mastitis. CMT could be used for bulk tank and individual cow sample monitoring, as well as for determining the quarter of the udder that is mastitic. In addition, it offers Rapid Johne?s Test, which identifies the cattle with symptomatic Johne?s disease in a herd. Further, the company focuses on the development of Mast Out, an intramammary infusion product containing Nisin for use in the treatment of mastitis in lactating dairy cows. It sells its products to dairy producers, bovine veterinarians, and veterinary laboratories directly, as well as through veterinarian distributors. The company was founded in 1982 and is based in Portland, Maine.